Find stats on top websites
Industry Landscape
The AI in medical imaging industry is experiencing rapid innovation, driven by advancements in AI, cloud computing, and increasing demand for improved diagnostic accuracy and efficiency. Integration with existing healthcare IT systems and regulatory compliance (like FDA, HIPAA) are key focuses. The market is competitive with significant growth potential, moving towards more intelligent and accessible solutions.
Total Assets Under Management (AUM)
Medical Imaging Market Size in United States
~Approximately 25-30 billion USD (2023 estimate for U.S. medical imaging market)
(5-7% CAGR)
- Driven by aging population and chronic diseases.
- Technological advancements in AI and imaging modalities.
- Increasing demand for early and accurate diagnostics.
Total Addressable Market
30 billion USD
Market Growth Stage
Pace of Market Growth
Emerging Technologies
Generative AI for Synthetic Data
Generative AI is increasingly used to create synthetic medical imaging data, addressing data scarcity for AI model training and enhancing privacy.
Federated Learning
Federated learning allows AI models to be trained on decentralized datasets across multiple healthcare institutions without sharing raw patient data, improving privacy and access to diverse data.
Edge AI in Medical Devices
Deploying AI directly on medical imaging devices (at the 'edge') enables real-time processing, reduces latency, and enhances data security by minimizing cloud transfers.
Impactful Policy Frameworks
FDA's Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan (2021)
This FDA plan outlines a framework for the regulation of AI/ML-based SaMD, focusing on a total product lifecycle approach that allows for modifications to algorithms based on real-world learning without requiring a new 510(k) submission for every change.
This policy streamlines the regulatory pathway for LifeVoxel's AI models, enabling faster iteration and deployment of improved algorithms without burdensome re-approvals.
Information Blocking Rule (21st Century Cures Act, 2021 enforcement)
Part of the 21st Century Cures Act, this rule prohibits healthcare providers, health IT developers, and health information exchanges from knowingly and unreasonably interfering with the access, exchange, or use of electronic health information (EHI).
This rule mandates greater interoperability and data sharing, which benefits LifeVoxel by facilitating easier integration with diverse healthcare IT systems and enabling patients to access their imaging data more readily.
NIST AI Risk Management Framework (AI RMF 1.0, 2023)
The National Institute of Standards and Technology (NIST) released a voluntary framework to help organizations manage the risks of artificial intelligence, emphasizing trustworthiness, transparency, and accountability.
While voluntary, this framework sets a standard for trustworthy AI, encouraging LifeVoxel to adopt best practices in AI development and deployment that will build customer trust and potentially become future regulatory requirements.
Transform Your Ideas into Action in Minutes with WaxWing
Sign up now and unleash the power of AI for your business growth
